An Oxford-based venture capital firm focussed on businesses harnessing science R and D to address global challenges.
Portfolio
3
companies
Lightcast Discovery
Lightcast Discovery builds a novel single-cell functional analysis platform for life science research.
MicrofluidX
MicrofluidX provides next-generation bioreactors for cell research and manufacturing.
Wayland Additive
Wayland Additive develops advanced electron beam 3D printing systems for industrial manufacturing.
David Denny
Partner
Rebecca Todd
M Ventures led the Series B round to support the company ahead of its commercial launch.
"The power of single-cell analysis to uncover the complexities of biology has become increasingly evident, but much of the work still focuses on the transcriptome as the primary readout."
The Stevenage enterprise raised the capital from Longwall Ventures and a syndicate of backers to fund trials and product development.
"Advanced therapy manufacturing is hindered by out of date, inadequate manufacturing technologies,"
The seed round was led by UKI2S and Longwall Ventures to support cell therapy bioprocessing development.
"We are thrilled to close this initial funding round with help from UKI2S. We are continuing to establish partnerships with Biotech and Pharma, on top of our existing partnerships with the Cell and Gene Therapy Catapult and the Centre for Process Innovation. The funding will be used to further develop our technology, as well as fund trials with our partners."
Longwall Ventures and the Angel CoFund led the Series A round to support the development of advanced metal 3D printing systems.
"Additive Manufacturing is currently one of the fastest growing, disruptive technology spaces, providing manufacturers with the ability to produce high value components that would have been impossible even ten years ago. We are excited to be developing our new product in such a high-potential market, and look forward to driving its rapid growth as we prepare to launch in the coming years."
